Investing Profile

Greg Yap

InvestorVC
Partner at Menlo Ventures
menlovc.com/greg-yapPalo Alto, California
Photo of Greg Yap, Partner at Menlo Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$8.0M - $15.0M
$12.0M
35
$500M
CompanyStageDateRound SizeTotal Raised
Aurora Therapeutics
SeedJan 2026$16M
$16M
Chai Discovery
Series BDec 2025$130M
Series AAug 2025$70M
$200M
Co-investors: Elena Viboch (General Catalyst), Fred Ehrsam (Paradigm), Lachy Groom (LGF), Annie Lamont (Oak HC/FT)
Heidi Health
Series AMar 2025$17M
$82M
Co-investors: Taylor Brandt (Headline (formerly e.ventures)), Sri Chandrasekar (Point72 Ventures)
Clear Labs
Series DJan 2025$30M
Series CMay 2021$60M
Series UnknownMay 2020$21M
Series BOct 2018$21M
$150M
Co-investors: Chris Sklarin (Alumni Ventures ), Karl Handelsman (Codon Capital), Miguel Valls (Alta Life Sciences), Kyle Kurpinski (Tencent Holdings)
Vilya
Series AJun 2024$21M
$71M
Co-investors: Steven Gillis (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners)
Xaira Therapeutics
Series AApr 2024$1B
$1B
Co-investors: Scott Gottlieb (New Enterprise Associates (NEA)), Vikram Bajaj (Foresite Capital), Robert Nelsen (ARCH Venture Partners)
Cartwheel
Series ASep 2023$20M
$40M
Co-investors: Reva Nohria (General Catalyst), Holly Maloney McConnell (General Catalyst), Lainy Painter (Craft Ventures), Minnie Ingersoll (TenOneTen Ventures), Amjad Masad
Delfi Diagnostics
Series BJul 2022$230M
Series AJan 2021$100M
SeedAug 2019$6M
$330M
Co-investors: Rishi Gupta (OrbiMed), Justin Kao (DFJ Growth)